VDR-dependent regulation of mast cell maturation mediated by 1,25-dihydroxyvitamin D3

Journal of Leukocyte Biology

Volumn 81, Issue 1, 2007, Pages 250-262

  Baroni, Enrico ^a   Biffi, Mauro ^a   Benigni, Fabio ^a   Monno, Antonia ^a   Carlucci, Donatella ^a   Carmeliet, Geert ^b   Bouillon, Roger ^b   D'Ambrosio, Daniele ^a  

^a BioXell SpA   (Italy)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Apoptosis; Bone marrow; Cell surface molecules; Maturation

Indexed keywords

CALCITRIOL; INTERLEUKIN 3 RECEPTOR; STEM CELL FACTOR; VITAMIN D RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL DENSITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; FEMALE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INFLAMMATION MEDIATORS; MAST CELLS; MICE; MICE, INBRED BALB C; RECEPTORS, CALCITRIOL; RECEPTORS, INTERLEUKIN-3; SKIN; VITAMIN D;

ANIMALIA;

EID: 33845890280     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0506322     Document Type: Article

References (57)

1. Brown, A. J., Dusso, A., Slatopolsky, E. (1999) Vitamin D. Am. J. Physiol. 277, F157-F175.
2. Penna, G., Adorini, L. (2000) 1 α,25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 164, 2405-2411.
3. Adorini, L., Giarratana, N., Penna, G. (2004) Pharmacological induction of tolerogenic dendritic cells and regulatory T cells. Semin. Immunol. 16, 127-134.
4. Mathieu, C., Adorini, L. (2002) The coming of age of 1,25- dihydroxyvitamin D(3) analogs as immunomodulatory agents. Trends Mol. Med. 8, 174-179.
5. Adorini, L. (2005) Intervention in autoimmunity: the potential of vitamin D receptor agonists. Cell. Immunol. 233, 115-124.
6. Galli, S. J. (1997) Complexity and redundancy in the pathogenesis of asthma: reassessing the roles of mast cells and T cells. J. Exp. Med. 186, 343-347.
7. Kawakami, T., Galli, S. J. (2002) Regulation of mast-cell and basophil function and survival by IgE. Nat. Rev. Immunol. 2, 773-786.
8. Brandt, E. B., Strait, R. T., Hershko, D., Wang, Q., Muntel, E. E., Scribner, T. A., Zimmermann, N., Finkelman, F. D., Rothenberg, M. E. (2003) Mast cells are required for experimental oral allergen-induced diarrhea. J. Clin. Invest. 112, 1666-1677.
9. Theoharides, T. C., Donelan, J. M., Papadopoulou, N., Cao, J., Kempuraj, D., Conti, P. (2004) Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol. Sci. 25, 563-568.
10. Oehlke, J., Lorenz, D., Wiesner, B., Bienert, M. (2005) Studies on the cellular uptake of substance P and lysine-rich, KLA-derived model peptides. J. Mol. Recognit. 18, 50-59.
11. Metcalfe, D. D., Baram, D., Mekori, Y. A. (1997) Mast cells. Physiol. Rev. 77, 1033-1079.
12. Levi-Schaffer, F., Shalit, M. (1989) Differential release of histamine and prostaglandin D2 in rat peritoneal mast cells activated with peptides. Int. Arch. Allergy Appl. Immunol. 90, 352-357.
13. Ogasawara, T., Murakami, M., Suzuki-Nishimura, T., Uchida, M. K., Kudo, I. (1997) Mouse bone marrow-derived mast cells undergo exocytosis, prostanoid generation, and cytokine expression in response to G protein-activating polybasic compounds after coculture with fibroblasts in the presence of c-kit ligand. J. Immunol. 158, 393-404.
14. Gagari, E., Tsai, M., Lantz, C. S., Fox, L. G., Galli, S. J. (1997) Differential release of mast cell interleukin-6 via c-kit. Blood 89, 2654-2663.
15. Karimi, K., Kool, M., Nijkamp, F. P., Redegeld, F. A. (2004) Substance P can stimulate prostaglandin D2 and leukotriene C4 generation without granule exocytosis in murine mast cells. Eur. J. Pharmacol. 489, 49-54.
16. Babina, M., Krautheim, M., Grutzkau, A., Henz, B. M. (2000) Human leukemic (HMC-1) mast cells are responsive to 1α, 25-dihydroxyvitamin D(3): selective promotion of ICAM-3 expression and constitutive presence of vitamin D(3) receptor. Biochem. Biophys. Res. Commun. 273, 1104-1110.
17. Toyota, N., Sakai, H., Takahashi, H., Hashimoto, Y., Iizuka, H. (1996) Inhibitory effect of 1 α,25-dihydroxyvitamin D3 on mast cell proliferation and A23187-induced histamine release, also accompanied by a decreased c-kit receptor. Arch. Dermatol. Res. 288, 709-715.
18. Shalita-Chesner, M., Koren, R., Mekori, Y. A., Baram, D., Rotem, C., Liberman, U. A., Ravid, A. (1998) 1,25-Dihydroxyvitamin D3 enhances degranulation of mast cells. Mol. Cell. Endocrinol. 142, 49-55.
19. Van Cromphaut, S. J., Dewerchin, M., Hoenderop, J. G., Stockmans, I., Van Herck, E., Kato, S., Bindels, R. J., Collen, D., Carmeliet, P., Bouillon, R., Carmeliet, G. (2001) Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects. Proc. Natl. Acad. Sci. USA 98, 13324-13329.
20. Ortega, E., Schweitzer-Stenner, R., Pecht, I. (1988) Possible orientational constraints determine secretory signals induced by aggregation of IgE receptors on mast cells. EMBO J. 7, 4101-4109.
21. Valent, P., Ashman, L. K., Hinterberger, W., Eckersberger, F., Majdic, O., Lechner, K., Bettelheim, P. (1989) Mast cell typing: demonstration of a distinct hematopoietic cell type and evidence for immunophenotypic relationship to mononuclear phagocytes. Blood 73, 1778-1785.
22. Malloy, P. J., Hochberg, Z., Pike, J. W., Feldman, D. (1989) Abnormal binding of vitamin D receptors to deoxyribonucleic acid in a kindred with vitamin D-dependent rickets, type II. J. Clin. Endocrinol. Metab. 68, 263-269.
23. Ishizaka, T., Ishizaka, K. (1984) Activation of mast cells for mediator release through IgE receptors. Prog. Allergy 34, 188-235.
24. Ishizaka, T., Conrad, D. H., Schulman, E. S., Sterk, A. R., Ko, C. G., Ishizaka, K. (1984) IgE-mediated triggering signals for mediator release from human mast cells and basophils. Fed. Proc. 43, 2840-2845.
25. Rofolovitch, M., Amira, M., Ginsburg, H. (1987) Degranulation of in vitro differentiated mast cells stimulated by two monoclonal IgE specificities. Eur. J. Immunol. 17, 385-392.
26. Mekori, Y. A., Oh, C. K., Metcalfe, D. D. (1993) IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand. J. Immunol. 151, 3775-3784.
27. Kambe, N., Hiramatsu, H., Shimonaka, M., Fujino, H., Nishikomori, R., Heike, T., Ito, M., Kobayashi, K., Ueyama, Y., Matsuyoshi, N., Miyachi, Y., Nakahata, T. (2004) Development of both human connective tissue-type and mucosal-type mast cells in mice from hematopoietic stem cells with identical distribution pattern to human body. Blood 103, 860-867.
28. Galli, S. J., Wershil, B. K. (1996) The two faces of the mast cell. Nature 381, 21-22.
29. Galli, S. J. (1993) New concepts about the mast cell. N. Engl. J. Med. 328, 257-265.
30. Metcalfe, D. D., Akin, C. (2001) Mastocytosis: molecular mechanisms and clinical disease heterogeneity. Leuk. Res. 25, 577-582.
31. Xie, H., He, S. H. (2005) Roles of histamine and its receptors in allergic and inflammatory bowel diseases. World J. Gastroenterol. 11, 2851-2857.
32. Valent, P., Akin, C., Sperr, W. R., Mayerhofer, M., Fodinger, M., Fritsche-Polanz, R., Sotlar, K., Escribano, L., Arock, M., Horny, H. P., Metcalfe, D. D. (2005) Mastocytosis: pathology, genetics, and current options for therapy. Leuk. Lymphoma 46, 35-48.
33. Reber, L., Da Silva, C. A., Frossard, N. (2006) Stem cell factor and its receptor c-Kit as targets for inflammatory diseases. Eur. J. Pharmacol. 533, 327-340.
34. Puxeddu, I., Ribatti, D., Crivellato, E., Levi-Schaffer, F. (2005) Mast cells and eosinophils: a novel link between inflammation and angiogenesis in allergic diseases. J. Allergy Clin. Immunol. 116, 531-536.
35. Chang, T. W., Shiung, Y. Y. (2006) Anti-IgE as a mast cell-stabilizing therapeutic agent. J. Allergy Clin. Immunol. 117, 1203-1212.
36. Lantz, C. S., Huff, T. F. (1995) Differential responsiveness of purified mouse c-kit+ mast cells and their progenitors to IL-3 and stem cell factor. J. Immunol. 155, 4024-4029.
37. Tsuji, K., Zsebo, K. M., Ogawa, M. (1991) Murine mast cell colony formation supported by IL-3, IL-4, and recombinant rat stem cell factor, ligand for c-kit. J. Cell. Physiol. 148, 362-369.
38. Lantz, C. S., Boesiger, J., Song, C. H., Mach, N., Kobayashi, T., Mulligan, R. C., Nawa, Y., Dranoff, G., Galli, S. J. (1998) Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites. Nature 392, 90-93.
39. Ody, C., Kindler, V., Vassalli, P. (1990) Interleukin 3 perfusion in W/Wv mice allows the development of macroscopic hematopoietic spleen colonies and restores cutaneous mast cell number. J. Exp. Med. 172, 403-406.
40. Rodewald, H. R., Dessing, M., Dvorak, A. M., Galli, S. J. (1996) Identification of a committed precursor for the mast cell lineage. Science 271, 818-822.
41. Chen, C. C., Grimbaldeston, M. A., Tsai, M., Weissman, I. L., Galli, S. J. (2005) Identification of mast cell progenitors in adult mice. Proc. Natl. Acad. Sci. USA 102, 11408-11413.
42. Lantz, C. S., Huff, T. F. (1995) Murine kit+ lineage-bone marrow progenitors express Fc γ-RII but do not express Fc ε-RI until mast cell granule formation. J. Immunol. 154, 355-362.
43. Dvorak, A. M., Seder, R. A., Paul, W. E., Morgan, E. S., Galli, S. J. (1994) Effects of interleukin-3 with or without the c-kit ligand, stem cell factor, on the survival and cytoplasmic granule formation of mouse basophils and mast cells in vitro. Am. J. Pathol. 144, 160-170.
44. Thompson, H. L., Metcalfe, D. D., Kinet, J. P. (1990) Early expression of high-affinity receptor for immunoglobulin E (Fc ε RI) during differentiation of mouse mast cells and human basophils. J. Clin. Invest. 85, 1227-1233.
45. Rottem, M., Barbieri, S., Kinet, J. P., Metcalfe, D. D. (1992) Kinetics of the appearance of Fc ε RI-bearing cells in interleukin-3-dependent mouse bone marrow cultures: correlation with histamine content and mast cell maturation. Blood 79, 972-980.
46. Boonstra, A., Barrat, F. J., Crain, C., Heath, V. L., Savelkoul, H. F., O'Garra, A. (2001) 1α,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J. Immunol. 167, 4974-4980.
47. Lemire, J. M., Archer, D. C., Beck, L., Spiegelberg, H. L. (1995) Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J. Nutr. 125, 1704S-1708S.
48. Staeva-Vieira, T. P., Freedman, L. P. (2002) 1,25-Dihydroxyvitamin D3 inhibits IFN-γ and IL-4 levels during in vitro polarization of primary murine CD4+ T cells. J. Immunol. 168, 1181-1189.
49. O'Kelly, J., Hisatake, J., Hisatake, Y., Bishop, J., Norman, A., Koeffler, H. P. (2002) Normal myelopoiesis but abnormal T lymphocyte responses in vitamin D receptor knockout mice. J. Clin. Invest. 109, 1091-1099.
50. Wittke, A., Weaver, V., Mahon, B. D., August, A., Cantorna, M. T. (2004) Vitamin D receptor-deficient mice fail to develop experimental allergic asthma. J. Immunol. 173, 3432-3436.
51. D'Ambrosio, D. (2005) Increased IgE but reduced Th2-type inflammation in vitamin D receptor-deficient mice. J. Immunol. 174, 4451.
52. Xystrakis, E., Boswell, S. E., Hawrylowicz, C. M. (2006) T regulatory cells and the control of allergic disease. Expert Opin. Biol. Ther. 6, 121-133.
53. Topilski, I., Flaishon, L., Naveh, Y., Harmelin, A., Levo, Y., Shachar, I. (2004) The anti-inflammatory effects of 1,25-dihydroxyvitamin D3 on Th2 cells in vivo are due in part to the control of integrin-mediated T lymphocyte homing. Eur. J. Immunol. 34, 1068-1076.
54. Benigni, F., Baroni, E., Zecevic, M., Zvara, P., Streng, T., Hedlund, P., Colli, E., D'Ambrosio, D., Andersson, K. E. (2006) Oral treatment with a vitamin D3 analogue (BXL628) has anti-inflammatory effects in rodent model of interstitial cystitis. BJU Int. 97, 617-624.
55. Guyton, K. Z., Kensler, T. W., Posner, G. H. (2003) Vitamin D and vitamin D analogs as cancer chemopreventive agents. Nutr. Rev. 61, 227-238.
56. Johnson, C. S., Hershberger, P. A., Bernardi, R. J., McGuire, T. F., Trump, D. L. (2002) Vitamin D receptor: a potential target for intervention. Urology 60, 123-130.
57. Clohisy, D. R., Bar-Shavit, Z., Chappel, J. C., Teitelbaum, S. L. (1987) 1,25-Dihydroxyvitamin D3 modulates bone marrow macrophage precursor proliferation and differentiation. Up-regulation of the mannose receptor. J. Biol. Chem. 262, 15922-15929.